1. Home
  2. ARCT vs MYN Comparison

ARCT vs MYN Comparison

Compare ARCT & MYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • MYN
  • Stock Information
  • Founded
  • ARCT 2013
  • MYN 1992
  • Country
  • ARCT United States
  • MYN United States
  • Employees
  • ARCT N/A
  • MYN N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • MYN Finance Companies
  • Sector
  • ARCT Health Care
  • MYN Finance
  • Exchange
  • ARCT Nasdaq
  • MYN Nasdaq
  • Market Cap
  • ARCT 373.7M
  • MYN 358.2M
  • IPO Year
  • ARCT N/A
  • MYN N/A
  • Fundamental
  • Price
  • ARCT $14.94
  • MYN $9.19
  • Analyst Decision
  • ARCT Strong Buy
  • MYN
  • Analyst Count
  • ARCT 8
  • MYN 0
  • Target Price
  • ARCT $52.83
  • MYN N/A
  • AVG Volume (30 Days)
  • ARCT 443.2K
  • MYN 86.0K
  • Earning Date
  • ARCT 08-04-2025
  • MYN 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • MYN 4.12%
  • EPS Growth
  • ARCT N/A
  • MYN N/A
  • EPS
  • ARCT N/A
  • MYN N/A
  • Revenue
  • ARCT $143,680,000.00
  • MYN N/A
  • Revenue This Year
  • ARCT N/A
  • MYN N/A
  • Revenue Next Year
  • ARCT $34.08
  • MYN N/A
  • P/E Ratio
  • ARCT N/A
  • MYN N/A
  • Revenue Growth
  • ARCT 15.38
  • MYN N/A
  • 52 Week Low
  • ARCT $8.04
  • MYN $8.47
  • 52 Week High
  • ARCT $25.88
  • MYN $10.62
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 60.54
  • MYN 30.19
  • Support Level
  • ARCT $12.75
  • MYN $9.14
  • Resistance Level
  • ARCT $15.83
  • MYN $9.25
  • Average True Range (ATR)
  • ARCT 0.86
  • MYN 0.07
  • MACD
  • ARCT 0.12
  • MYN -0.02
  • Stochastic Oscillator
  • ARCT 71.10
  • MYN 11.54

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About MYN Blackrock MuniYield New York Quality Fund Inc.Common Stock

Blackrock Muniyield NY Quality FD, Inc is a closed-end management investment company. Its objective is to provide shareholders with a high level of current income exempt from federal income taxes. The Fund invests in long-term municipal obligations that are investment grade quality or are considered by the Fund's investment adviser to be of comparable quality, at the time of investment.

Share on Social Networks: